WHO ICTRP trial
A Study to Investigate the Safety of SEP-786 101 Capsules Compared With Placebo…
ACTRN12624000898550 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12624000898550 |
|---|---|
| Public title | A Study to Investigate the Safety of SEP-786 101 Capsules Compared With Placebo Capsules in Healthy Volunteer Participants Aged 24 Through 55 Years |
| Scientific title | A Phase 1, Double Blind, Randomized, Placebo Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Doses of SEP-786 in Healthy Adult Participants (SEP-786 Phase 1 SAD and MAD) |
| Primary sponsor | Septerna, Inc. |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Hypoparathyroidism; Hypoparathyroidism;Metabolic and Endocrine - Other endocrine disorders |
| Interventions | This study will be conducted in to 3 parts. Part 1 will evaluate single ascending doses (SAD) of SEP-786 administered orally as capsule on Day 1 in healthy participants. It will consist of a maximum of 8 cohorts and each cohort will consist… |
| Registration date | Jul 24, 2024 |
| Target size | 180 |
| Secondary IDs | SEP-786-101 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: